CinnoRA® is the brand name of adalimumab. Each autoinjector of CinnoRA® contains 40 mg adalimumab as an active ingredient in 0.8 ml solution.CinnoRA® is used to reduce signs and symptoms of rheumatoid arthritis (RA), as well as to prevent the development of structural damage, and to improve physical function of adult patients with moderate to severe RA who did not respond well enough to one or more of the disease-modifying antirheumatic drugs. Your doctor will decide if CinnoRA® should be used alone or in combination with other medications. CinnoRA® can also be used in juvenile idiopathic arthritis (≥2 years of age), psoriatic arthritis, ankylosing spondylitis, Crohn’s disease in adults or children (≥6 years of age), ulcerative colitis, plaque psoriasis, hidradenitis suppurativa in adults and adolescents (≥12 years of age), and non-infectious uveitis in adults and children (≥2 years of age)
